Melanin concentrating hormone receptor antagonist
US7659276B2 · kind B2 · utility
0Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2009 |
| Grant date | Feb 9, 2010 |
| Priority date | — |
| Expiry date | Feb 6, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds, or pharmaceutically-acceptable salts, tautomers or prodrugs thereof, of Formula Iwherein A, W, X, Z, R1-R3, and R8 are as defined in the specification, are provided. Also provided are methods of treating or preventing a melanin concentrating hormone-mediated disorder in a subject, comprising administering to a subject in need of such treatment or prevention a compound of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.